Literature DB >> 11769637

[Study on anti-HBV effects by antisense oligodeoxynucleotides in vitro].

S Liu1, W Sun, Y Cao.   

Abstract

OBJECTIVE: To study the inhibition effect of anti-HIV oligodeoxy-nucleotides on HBV X gene.
METHODS: Three antisense phosphorothioate oligodeoxy-nucleotides(AsON) complementary to the initiator of X, DR2, EN II respectively, were synthesized and tested for their anti-HBV activity on HepG2.2.15 cells with ELISA methods.
RESULTS: When the best effect concentration of AsON was 10 mumol/L, the inhibition rates on HBsAg of three AsON were 57%, 60% and 52% respectively, and on HBeAg were 56%, 45% and 56% respectively. There were two inhibition peaks at different times. There was no inhibition effect treated by random control (< 12%). Using the 3-(4,5-dimethythiazol-xyl)-2,5-diphnyl tetrazolium bromide method, there was no cytotoxicity at 40 mumol/L of AsON.
CONCLUSION: AsONs on three key region of X gene were effective drugs to inhibit the expression of HBV.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11769637

Source DB:  PubMed          Journal:  Zhonghua Yu Fang Yi Xue Za Zhi        ISSN: 0253-9624


  1 in total

1.  Distribution and anti-HBV effects of antisense oligodeoxynucleotides conjugated to galactosylated poly-L-lysine.

Authors:  Su-Jun Zheng; Sen Zhong; Jian-Jun Zhang; Feng Chen; Hong Ren; Cun-Liang Deng
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.